These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 16310388

  • 1. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma.
    Buhl R, Vinkler I, Magyar P, Györi Z, Rybacki C, Middle MV, Escher A, Engelstätter R.
    Pulm Pharmacol Ther; 2006; 19(6):404-12. PubMed ID: 16310388
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S, Engelstätter R, Weber HJ, Hirsch S, Barkai L, Emeryk A, Weber H, Vermeulen J.
    Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
    [Abstract] [Full Text] [Related]

  • 3. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED, Linnhof AE, Homik L, Freudensprung U, Smau L, Engelstätter R.
    Pulm Pharmacol Ther; 2008 Jun; 21(2):264-75. PubMed ID: 17604664
    [Abstract] [Full Text] [Related]

  • 4. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma.
    Dahl R, Engelstätter R, Trebas-Pietraś E, Kuna P.
    Respir Med; 2010 Aug; 104(8):1121-30. PubMed ID: 20430601
    [Abstract] [Full Text] [Related]

  • 5. Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma.
    Magnussen H, Hofman J, Staneta P, Lawo JP, Hellwig M, Engelstätter R.
    J Asthma; 2007 Sep; 44(7):555-63. PubMed ID: 17885859
    [Abstract] [Full Text] [Related]

  • 6. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma.
    Boulet LP, Bateman ED, Voves R, Müller T, Wolf S, Engelstätter R.
    Respir Med; 2007 Aug; 101(8):1677-86. PubMed ID: 17448650
    [Abstract] [Full Text] [Related]

  • 7. Difference between patient-reported side effects of ciclesonide versus fluticasone propionate.
    van der Molen T, Foster JM, Caeser M, Müller T, Postma DS.
    Respir Med; 2010 Dec; 104(12):1825-33. PubMed ID: 20584595
    [Abstract] [Full Text] [Related]

  • 8. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

  • 9. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 10. Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.
    Bateman ED, Cheung D, Lapa e Silva J, Göhring UM, Schäfer M, Engelstätter R.
    Pulm Pharmacol Ther; 2008 Mar; 21(3):489-98. PubMed ID: 18178494
    [Abstract] [Full Text] [Related]

  • 11. Ciclesonide is more effective than budesonide in the treatment of persistent asthma.
    Ukena D, Biberger C, Steinijans V, von Behren V, Malek R, Weber HH, Beck E, Linnhoff A.
    Pulm Pharmacol Ther; 2007 Mar; 20(5):562-70. PubMed ID: 16962345
    [Abstract] [Full Text] [Related]

  • 12. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
    Derom E, Van De Velde V, Marissens S, Engelstätter R, Vincken W, Pauwels R.
    Pulm Pharmacol Ther; 2005 Mar; 18(5):328-36. PubMed ID: 15939311
    [Abstract] [Full Text] [Related]

  • 13. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
    Chapman KR, Patel P, D'Urzo AD, Alexander M, Mehra S, Oedekoven C, Engelstätter R, Boulet LP.
    Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
    [Abstract] [Full Text] [Related]

  • 14. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
    Boulet LP, Drollmann A, Magyar P, Timar M, Knight A, Engelstätter R, Fabbri L.
    Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
    [Abstract] [Full Text] [Related]

  • 15. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 17. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
    Lipworth BJ, Kaliner MA, LaForce CF, Baker JW, Kaiser HB, Amin D, Kundu S, Williams JE, Engelstaetter R, Banerji DD.
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
    [Abstract] [Full Text] [Related]

  • 18. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma.
    Vermeulen JH, Gyurkovits K, Rauer H, Engelstätter R.
    Respir Med; 2007 Oct; 101(10):2182-91. PubMed ID: 17614270
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H, Orozco S, Allen A.
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [Abstract] [Full Text] [Related]

  • 20. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.